Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jae Young So

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|December 3, 2014
Targeting cancer stem cells in solid tumors by vitamin DJae Young So, Nanjoo Suh
Pharmacology & Therapeutics|July 25, 2022
Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment optionsJae Young So, Joyce Ohm, Stan Lipkowitz, et al.
Molecular and Cellular Pharmacology|February 22, 2014
Differential Expression of Key Signaling Proteins in MCF10 Cell Lines, a Human Breast Cancer Progression ModelJae Young So, Hong Jin Lee, Pavel Kramata, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 3, 2014
Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancerJoseph Wahler, Jae Young So, Larry C Cheng, et al.
International Journal of Molecular Sciences|August 26, 2022
CXCL14 Attenuates Triple-Negative Breast Cancer Progression by Regulating Immune Profiles of the Tumor Microenvironment in a T Cell-Dependent MannerCarla Gibbs, Jae Young So, Abdul Ahad, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 22, 2016
Structural analysis and biological activities of BXL0124, a gemini analog of vitamin DAnna Y Belorusova, Nanjoo Suh, Hong Jin Lee, et al.
Plos One|September 18, 2014
A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancerJae Young So, Janice J Lin, Joseph Wahler, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 3, 2014
Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analogJoseph Wahler, Jae Young So, Yeoun Chan Kim, et al.
Plos One|January 18, 2013
Targeting CD44-STAT3 signaling by Gemini vitamin D analog leads to inhibition of invasion in basal-like breast cancerJae Young So, Amanda K Smolarek, David M Salerno, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 27, 2014
HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancerJae Young So, Joseph Wahler, Soumyasri Das Gupta, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The Journal of Steroid Biochemistry and Molecular Biology|December 3, 2014
Targeting cancer stem cells in solid tumors by vitamin DJae Young So, Nanjoo Suh
Pharmacology & Therapeutics|July 25, 2022
Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment optionsJae Young So, Joyce Ohm, Stan Lipkowitz, et al.
Molecular and Cellular Pharmacology|February 22, 2014
Differential Expression of Key Signaling Proteins in MCF10 Cell Lines, a Human Breast Cancer Progression ModelJae Young So, Hong Jin Lee, Pavel Kramata, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 3, 2014
Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancerJoseph Wahler, Jae Young So, Larry C Cheng, et al.
International Journal of Molecular Sciences|August 26, 2022
CXCL14 Attenuates Triple-Negative Breast Cancer Progression by Regulating Immune Profiles of the Tumor Microenvironment in a T Cell-Dependent MannerCarla Gibbs, Jae Young So, Abdul Ahad, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 22, 2016
Structural analysis and biological activities of BXL0124, a gemini analog of vitamin DAnna Y Belorusova, Nanjoo Suh, Hong Jin Lee, et al.
Plos One|September 18, 2014
A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancerJae Young So, Janice J Lin, Joseph Wahler, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 3, 2014
Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analogJoseph Wahler, Jae Young So, Yeoun Chan Kim, et al.
Plos One|January 18, 2013
Targeting CD44-STAT3 signaling by Gemini vitamin D analog leads to inhibition of invasion in basal-like breast cancerJae Young So, Amanda K Smolarek, David M Salerno, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 27, 2014
HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancerJae Young So, Joseph Wahler, Soumyasri Das Gupta, et al.
Pageof 3